Pacira Biosciences, Inc. (PCRX)
23.41
+0.30
(+1.30%)
USD |
NASDAQ |
Feb 24, 16:00
23.41
0.00 (0.00%)
After-Hours: 20:00
Pacira Biosciences Research and Development Expense (Quarterly) : 25.97M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 23.74M |
| CorMedix, Inc. | 5.098M |
| Krystal Biotech, Inc. | 13.23M |
| Arcutis Biotherapeutics, Inc. | 19.60M |
| ADMA Biologics, Inc. | 1.528M |